A growing body of evidence indicates that expression of NKCC1 protein is closely related to tumor progression, such as lung adenocarcinoma (Sun et al., 2016), prostate cancer cells (Hiraoka et al., 2010), and esophageal squamous carcinoma cells (Shiozaki et al., 2014). This evidence concerns the gene SLC12A2 and prostate carcinoma.